Details of the Drug Formulations

General Information of Drug (ID: DMV0RNS)

Drug Name
Deflazacort Drug Info
Synonyms C25H33NO6; Deflazacort (Calcort); Deflazacortum [INN-Latin]; EINECS 238-483-7; Deflan (TN); D09WYX; AC1L1BQ2; Deflazacort [USAN:BAN:INN]; CTK8F9001; MolPort-035-394-927
Indication
Disease Entry ICD 11 Status REF
Duchenne dystrophy 8C70 Approved [1]
Cross-matching ID
PubChem CID
189821
ChEBI ID
CHEBI:135720
CAS Number
14484-47-0
TTD ID
D09WYX
VARIDT ID
DR00146
INTEDE ID
DR0430
ACDINA ID
D00174

Full List of Drug Formulations Containing This Drug

Deflazacort 18 mg tablet
Company Formulation ID FDA Description
Marathon Pharmaceuticals F05284 Lactose monohydrate; Magnesium stearate; Silicon dioxide
------------------------------------------------------------------------------------
Deflazacort 30 mg tablet
Company Formulation ID FDA Description
Marathon Pharmaceuticals F05285 Lactose monohydrate; Magnesium stearate; Silicon dioxide
------------------------------------------------------------------------------------
Deflazacort 36 mg tablet
Company Formulation ID FDA Description
Marathon Pharmaceuticals F05286 Lactose monohydrate; Magnesium stearate; Silicon dioxide
------------------------------------------------------------------------------------
Deflazacort 6 mg tablet
Company Formulation ID FDA Description
Marathon Pharmaceuticals F05287 Lactose monohydrate; Magnesium stearate; Silicon dioxide
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015